Deutsche Bank Ag\ Innoviva, Inc. Transaction History
Deutsche Bank Ag\
- $248 Billion
- Q4 2024
A detailed history of Deutsche Bank Ag\ transactions in Innoviva, Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 24,700 shares of INVA stock, worth $446,575. This represents 0.0% of its overall portfolio holdings.
Number of Shares
24,700
Previous 848,153
97.09%
Holding current value
$446,575
Previous $16.4 Million
97.39%
% of portfolio
0.0%
Previous 0.01%
Shares
33 transactions
Others Institutions Holding INVA
# of Institutions
240Shares Held
77MCall Options Held
53.9KPut Options Held
300-
Black Rock Inc. New York, NY9.63MShares$174 Million0.0% of portfolio
-
Sarissa Capital Management LP Greenwich, CT7.28MShares$132 Million39.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.31MShares$114 Million0.0% of portfolio
-
Putnam Investments LLC Boston, MA6.27MShares$113 Million0.14% of portfolio
-
Dimensional Fund Advisors LP Austin, TX4.92MShares$88.9 Million0.02% of portfolio
About Innoviva, Inc.
- Ticker INVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 69,706,000
- Market Cap $1.26B
- Description
- Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...